Outcomes of Percutaneous Cholecystostomy in Older Adults with Acute Cholecystitis.

IF 1.8 4区 医学 Q2 MEDICINE, GENERAL & INTERNAL
Israel Medical Association Journal Pub Date : 2025-04-01
Edden Slomowitz, Lisa Cooper, Hadas Tsivion-Visbord, Tzippy Shochat, Hanoch Kashtan, Ilan Schrier
{"title":"Outcomes of Percutaneous Cholecystostomy in Older Adults with Acute Cholecystitis.","authors":"Edden Slomowitz, Lisa Cooper, Hadas Tsivion-Visbord, Tzippy Shochat, Hanoch Kashtan, Ilan Schrier","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Acute cholecystitis (ACC) is one of the most common diagnoses encountered in surgical wards. A number of treatment modalities are available, and various guidelines have been developed to help decision making. Many factors influence treatment strategies, including patient age and frailty. Due to the increasing proportion of older patients, consideration into the best treatment modalities for this population are warranted.</p><p><strong>Objectives: </strong>To determine outcomes of elderly patients with ACC according to different treatment strategies.</p><p><strong>Methods: </strong>A retrospective analysis of consecutive patients aged ≥ 80 years who were admitted with a diagnosis of ACC between 2015 and 2019 to a single academic center. Patients were divided into three groups according to treatment: percutaneous cholecystostomy tube placement, cholecystectomy, intravenous antibiotic treatment only.</p><p><strong>Results: </strong>Overall, 466 patients were included in the cohort. The majority (approximately 75%) were treated with antibiotics only, 17% underwent percutaneous cholecystostomy, and 8% underwent laparoscopic cholecystectomy. One-year mortality was 28.1%. The highest mortality rate was 41.6% in the cholecystostomy group (P = 0.002). In multivariable analysis age, functional status, C-reactive protein, and albumin levels were found to be independent risk factors for 1-year mortality (hazard ratio [HR] 1.08, 0.56, 0.98, 0.4, respectively). Cholecystostomy increased risk of one-year mortality compared to cholecystectomy and antibiotics alone (HR 0.61, 0.23, respectively).</p><p><strong>Conclusions: </strong>The use of cholecystostomy for ACC in older adults is an independent risk factor for 1-year mortality. Its use in older adults should be reserved for carefully selected cases.</p>","PeriodicalId":50268,"journal":{"name":"Israel Medical Association Journal","volume":"27 4","pages":"249-254"},"PeriodicalIF":1.8000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Israel Medical Association Journal","FirstCategoryId":"3","ListUrlMain":"","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Acute cholecystitis (ACC) is one of the most common diagnoses encountered in surgical wards. A number of treatment modalities are available, and various guidelines have been developed to help decision making. Many factors influence treatment strategies, including patient age and frailty. Due to the increasing proportion of older patients, consideration into the best treatment modalities for this population are warranted.

Objectives: To determine outcomes of elderly patients with ACC according to different treatment strategies.

Methods: A retrospective analysis of consecutive patients aged ≥ 80 years who were admitted with a diagnosis of ACC between 2015 and 2019 to a single academic center. Patients were divided into three groups according to treatment: percutaneous cholecystostomy tube placement, cholecystectomy, intravenous antibiotic treatment only.

Results: Overall, 466 patients were included in the cohort. The majority (approximately 75%) were treated with antibiotics only, 17% underwent percutaneous cholecystostomy, and 8% underwent laparoscopic cholecystectomy. One-year mortality was 28.1%. The highest mortality rate was 41.6% in the cholecystostomy group (P = 0.002). In multivariable analysis age, functional status, C-reactive protein, and albumin levels were found to be independent risk factors for 1-year mortality (hazard ratio [HR] 1.08, 0.56, 0.98, 0.4, respectively). Cholecystostomy increased risk of one-year mortality compared to cholecystectomy and antibiotics alone (HR 0.61, 0.23, respectively).

Conclusions: The use of cholecystostomy for ACC in older adults is an independent risk factor for 1-year mortality. Its use in older adults should be reserved for carefully selected cases.

经皮胆囊造瘘术治疗老年急性胆囊炎的疗效。
背景:急性胆囊炎(ACC)是外科病房最常见的诊断之一。有许多治疗方式可供选择,并制定了各种指导方针以帮助决策。许多因素影响治疗策略,包括患者的年龄和虚弱。由于老年患者比例的增加,对这一人群的最佳治疗方式的考虑是必要的。目的:探讨不同治疗策略对老年ACC患者预后的影响。方法:回顾性分析2015年至2019年在单一学术中心诊断为ACC的连续≥80岁患者。根据治疗方法将患者分为经皮胆囊造瘘管置管组、胆囊切除术组和单纯静脉抗生素治疗组。结果:总体而言,466名患者被纳入队列。大多数(约75%)仅接受抗生素治疗,17%接受经皮胆囊造口术,8%接受腹腔镜胆囊切除术。一年死亡率为28.1%。胆囊造瘘组死亡率最高,为41.6% (P = 0.002)。在多变量分析中,年龄、功能状态、c反应蛋白和白蛋白水平是1年死亡率的独立危险因素(危险比[HR]分别为1.08、0.56、0.98、0.4)。与胆囊切除术和单独使用抗生素相比,胆囊造口术增加了一年死亡率的风险(HR分别为0.61和0.23)。结论:老年ACC患者采用胆囊造瘘术是1年死亡率的独立危险因素。它在老年人中的使用应谨慎选择的情况下保留。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Israel Medical Association Journal
Israel Medical Association Journal 医学-医学:内科
CiteScore
2.20
自引率
12.50%
发文量
54
审稿时长
3-8 weeks
期刊介绍: The Israel Medical Association Journal (IMAJ), representing medical sciences and medicine in Israel, is published in English by the Israel Medical Association. The Israel Medical Association Journal (IMAJ) was initiated in 1999.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信